-
EP1087788
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1087788
| EP1087788 - MUCOSAL TARGETING IMMUNISATION [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 19.11.2004 Database last updated on 26.06.2024 | Most recent event Tooltip | 19.11.2004 | Withdrawal of application | published on 05.01.2005 [2005/01] | Applicant(s) | For all designated states Aventis Pasteur 2, Avenue du Pont Pasteur 69367 Lyon Cedex 07 / FR | [N/P] |
| Former [2001/14] | For all designated states Aventis Pasteur 2, Avenue pont Pasteur 69367 Lyon Cedex 07 / FR | Inventor(s) | 01 /
JOURDIER, Thérèse Le Grillon, Bâtiment A, Chemin de Chantegrillet 69340 Francheville / FR | 02 /
MOSTE, Catherine 7, avenue Louis Momet F-69260 Charbonnières les Bains / FR | 03 /
MEIGNIER, Bernard 26, rue du 8 mai 1945 F-69510 Thurins / FR | [2001/14] | Representative(s) | Schaeffer, Nathalie Christiane, et al Sanofi Pasteur 2, avenue Pont Pasteur 69007 Lyon / FR | [N/P] |
| Former [2001/14] | Schaeffer, Nathalie Christiane, et al Aventis Pasteur SA, 2, avenue Pont Pasteur 69007 Lyon / FR | Application number, filing date | 99926558.0 | 28.06.1999 | [2001/14] | WO1999FR01554 | Priority number, date | FR19980008354 | 26.06.1998 Original published format: FR 9808354 | [2001/14] | Filing language | FR | Procedural language | FR | Publication | Type: | A1 Application with search report | No.: | WO0000218 | Date: | 06.01.2000 | Language: | FR | [2000/01] | Type: | A1 Application with search report | No.: | EP1087788 | Date: | 04.04.2001 | Language: | FR | The application published by WIPO in one of the EPO official languages on 06.01.2000 takes the place of the publication of the European patent application. | [2001/14] | Search report(s) | International search report - published on: | EP | 06.01.2000 | Classification | IPC: | A61K39/21, A61K39/245, A61K39/00, A61K39/29, A61K39/125, A61K39/235, A61K39/15, A61K39/12, A61K9/00, A61K9/48, // C07K14:16 | [2001/14] | CPC: |
C07K14/005 (EP,US);
A61K39/12 (EP,US);
A61K39/21 (EP,US);
A61K9/006 (EP,US);
A61K9/501 (EP,US);
A61K2039/5256 (EP,US);
A61K2039/542 (EP,US);
A61K2039/545 (EP,US);
A61K2039/55505 (EP,US);
A61K2039/55555 (EP,US);
A61K2039/55566 (EP,US);
A61K2039/55594 (EP,US);
A61K48/00 (EP,US);
A61K9/1635 (EP,US);
C12N2710/24043 (EP,US);
C12N2740/16122 (EP,US);
C12N2740/16134 (EP,US);
C12N2740/16234 (EP,US);
Y02A50/30 (EP,US)
(-)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [2001/14] | Title | German: | MUKOSALGEZIELTE IMMUNISIERUNG | [2001/14] | English: | MUCOSAL TARGETING IMMUNISATION | [2001/14] | French: | IMMUNISATION A CIBLAGE MUCOSAL | [2001/14] | Entry into regional phase | 26.01.2001 | National basic fee paid | 26.01.2001 | Designation fee(s) paid | 26.01.2001 | Examination fee paid | Examination procedure | 15.01.2000 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 10.01.2001 | Amendment by applicant (claims and/or description) | 26.01.2001 | Examination requested [2001/14] | 15.07.2003 | Despatch of a communication from the examining division (Time limit: M06) | 15.01.2004 | Reply to a communication from the examining division | 11.11.2004 | Application withdrawn by applicant [2005/01] | Fees paid | Renewal fee | 02.07.2001 | Renewal fee patent year 03 | 01.07.2002 | Renewal fee patent year 04 | 30.06.2003 | Renewal fee patent year 05 | 30.06.2004 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US4661350 (TSURUMIZU TAKASHI [JP], et al) [X] 1-5 * column 1, line 58 - column 2, line 11 * * column 5, line 56 - column 6, line 16 * * example 3 *; | [X]US3931398 (GAFFAR ABDUL, et al) [X] 1-5 * column 1, line 63 - column 2, line 8 * * column 3, line 63 - column 4, line 6 * * column 7, lines 3-12 *; | [X]WO9511700 (PHARMOS CORP [US], et al) [X] 1-9 * page 1, lines 5-9 * * page 5, lines 19-29 * * page 15, lines 11-18 * * page 19, lines 13-16 * * claims 1,13,14,24 * * figure 4 *; | [X]WO9620731 (VIAGENE INC [US]) [X] 1-3,5-9 * page 3, line 35 - page 4, line 14 * * page 9, lines 25-30 * * page 36, lines 3-15 * * claims 1,7,8 *; | [X] - HINKULA J ET AL, "Nucleic acid vaccination with HIV regulatory genes: a combination of HIV-1 genes in separate plasmids induces strong immune responses", VACCINE, (199706), vol. 15, no. 8, page 874-878, XP004075674 [X] 1-5 * the whole document * DOI: http://dx.doi.org/10.1016/S0264-410X(96)00257-5 | [X] - THIBODEAU L. ET AL., "Une immunisation orale et parentérale avec l'immunosome-VIH induit une sécrétion d'IgA spécifique du VIH-1 dans la salive et la production d'IgA circulants chez la souris et le lapin", C.R.ACAD.SCI.PARIS III, (1991), vol. 313, no. 9, pages 389 - 394, XP002096762 [X] 1-5 * the whole document * | [A] - RUSSELL M. W. ET AL., "Induction of the mucosal immune response", REV.INFECT.DIS., (198807), vol. 10, no. suppl 2, pages s440 - s446, XP002097165 [A] 1-5 * abstract * * tables 1,2 * | [PX] - MONTGOMERY P C ET AL, "Induction of secretory and serum antibody responses following oral administration of antigen with bioadhesive degradable starch microparticles.", ORAL MICROBIOLOGY AND IMMUNOLOGY, (1998 JUN) 13 (3) 139-49., XP002115802 [PX] 1-9 * abstract * * column 2, paragraph 3 - column 3, paragraph 2 * | [PA] - LUNDHOLM P ET AL, "Induction of mucosal IgA by a novel jet delivery technique for HIV -1 DNA.", VACCINE, (1999 APR 9) 17 (15-16) 2036-42., XP004165053 [PA] 1-9 * abstract * * page 2037, column L, paragraph 3 - column R, paragraph 3 * DOI: http://dx.doi.org/10.1016/S0264-410X(98)00404-6 |